The company is developing a drug to treat traumatic brain injury using a molecule extracted from marine macroalgae. This molecule targets the immune system to promote repair after brain trauma. The therapy aims to reduce stimulate the immune cells and enhance neurological recovery. We also work to valorise extraction by-products, ensuring a sustainable, biotech-driven approach to neurorepair. Expertise is sought in polysaccharide chemistry and extraction of molecules at pharmaceutical grade.
Ref. BRCO20251028017 Una biorrefinería colombiana busca socios europeos para colaborar en tecnologías biobasadas, renovables y circulares.
A Colombian bio-refinery specialized in sustainable biodiesel and glycerin production seeks European partners for two-way collaboration in bio-based products, renewable energy, and circular technologies. The company aims to act as a regional partner to...
Nov 20, 2025
















